跳至主要内容
临床试验/ISRCTN54112208
ISRCTN54112208已完成不适用

A study to assess whether complications of anti-coagulation treatment with vitamin K antagonists will diminish by supplementation of vitamin K

etherlands Heart Foundation (Nederlandse Hartstichting) (The Netherlands)0 个研究点目标入组 2,200 人开始时间: 2008年3月31日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Starting treatment with vitamin K antagonists less then four weeks before inclusion
  • 2. Treatment with vitamin K antagonists for a minimal period of six months, with the therapeutic range of International normalised ratio (INR) between 2.5 and 3.5
  • 3. Age between 18 and 85 years, either sex
  • 4. Measurement of the INR by the Thrombosis Service Leiden
  • 5. Informed consent

排除标准

  • 1. Treatment for liver failure
  • 2. Dialysis, both peritoneal and haemodialysys
  • 3. Pregnancy, or wish to get pregnant; lactational period
  • 4. Known to have a chronic condition with a life expectancy of less than six months
  • 5. An expected interruption of treatment with oral anti-coagulants for one week or longer
  • 6. Participation in the self-management protocol

研究者

发起方
etherlands Heart Foundation (Nederlandse Hartstichting) (The Netherlands)

相似试验